Azithromycin, a questionable treatment for COVID-19.
Identifieur interne : 000458 ( Main/Corpus ); précédent : 000457; suivant : 000459Azithromycin, a questionable treatment for COVID-19.
Auteurs : O. Belfaqeeh ; R N Janapala ; J. Patel ; A. Alhashmi ; A. PourmandSource :
- International journal of antimicrobial agents [ 1872-7913 ] ; 2021.
English descriptors
- KwdEn :
- MESH :
- chemical , therapeutic use : Azithromycin, Hydroxychloroquine, Lopinavir, Methylprednisolone, Ritonavir.
- drug effects : SARS-CoV-2.
- drug therapy : COVID-19.
- chemical : Drug Combinations, Drug Therapy, Combination, Humans.
DOI: 10.1016/j.ijantimicag.2021.106280
PubMed: 33476733
PubMed Central: PMC7817454
Links to Exploration step
pubmed:33476733Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Azithromycin, a questionable treatment for COVID-19.</title>
<author><name sortKey="Belfaqeeh, O" sort="Belfaqeeh, O" uniqKey="Belfaqeeh O" first="O" last="Belfaqeeh">O. Belfaqeeh</name>
<affiliation><nlm:affiliation>International Medicine Program, George Washington University School of Medicine and Health Sciences, Washington DC, USA. Electronic address: Obelfaqeeh@seha.ae.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Janapala, R N" sort="Janapala, R N" uniqKey="Janapala R" first="R N" last="Janapala">R N Janapala</name>
<affiliation><nlm:affiliation>International Medicine Program, George Washington University School of Medicine and Health Sciences, Washington DC, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Patel, J" sort="Patel, J" uniqKey="Patel J" first="J" last="Patel">J. Patel</name>
<affiliation><nlm:affiliation>International Medicine Program, George Washington University School of Medicine and Health Sciences, Washington DC, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Alhashmi, A" sort="Alhashmi, A" uniqKey="Alhashmi A" first="A" last="Alhashmi">A. Alhashmi</name>
<affiliation><nlm:affiliation>International Medicine Program, George Washington University School of Medicine and Health Sciences, Washington DC, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Pourmand, A" sort="Pourmand, A" uniqKey="Pourmand A" first="A" last="Pourmand">A. Pourmand</name>
<affiliation><nlm:affiliation>International Medicine Program, George Washington University School of Medicine and Health Sciences, Washington DC, USA.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2021">2021</date>
<idno type="RBID">pubmed:33476733</idno>
<idno type="pmid">33476733</idno>
<idno type="doi">10.1016/j.ijantimicag.2021.106280</idno>
<idno type="pmc">PMC7817454</idno>
<idno type="wicri:Area/Main/Corpus">000458</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000458</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Azithromycin, a questionable treatment for COVID-19.</title>
<author><name sortKey="Belfaqeeh, O" sort="Belfaqeeh, O" uniqKey="Belfaqeeh O" first="O" last="Belfaqeeh">O. Belfaqeeh</name>
<affiliation><nlm:affiliation>International Medicine Program, George Washington University School of Medicine and Health Sciences, Washington DC, USA. Electronic address: Obelfaqeeh@seha.ae.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Janapala, R N" sort="Janapala, R N" uniqKey="Janapala R" first="R N" last="Janapala">R N Janapala</name>
<affiliation><nlm:affiliation>International Medicine Program, George Washington University School of Medicine and Health Sciences, Washington DC, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Patel, J" sort="Patel, J" uniqKey="Patel J" first="J" last="Patel">J. Patel</name>
<affiliation><nlm:affiliation>International Medicine Program, George Washington University School of Medicine and Health Sciences, Washington DC, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Alhashmi, A" sort="Alhashmi, A" uniqKey="Alhashmi A" first="A" last="Alhashmi">A. Alhashmi</name>
<affiliation><nlm:affiliation>International Medicine Program, George Washington University School of Medicine and Health Sciences, Washington DC, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Pourmand, A" sort="Pourmand, A" uniqKey="Pourmand A" first="A" last="Pourmand">A. Pourmand</name>
<affiliation><nlm:affiliation>International Medicine Program, George Washington University School of Medicine and Health Sciences, Washington DC, USA.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">International journal of antimicrobial agents</title>
<idno type="eISSN">1872-7913</idno>
<imprint><date when="2021" type="published">2021</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Azithromycin (therapeutic use)</term>
<term>COVID-19 (drug therapy)</term>
<term>Drug Combinations (MeSH)</term>
<term>Drug Therapy, Combination (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Hydroxychloroquine (therapeutic use)</term>
<term>Lopinavir (therapeutic use)</term>
<term>Methylprednisolone (therapeutic use)</term>
<term>Ritonavir (therapeutic use)</term>
<term>SARS-CoV-2 (drug effects)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Azithromycin</term>
<term>Hydroxychloroquine</term>
<term>Lopinavir</term>
<term>Methylprednisolone</term>
<term>Ritonavir</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>SARS-CoV-2</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>COVID-19</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>Drug Combinations</term>
<term>Drug Therapy, Combination</term>
<term>Humans</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33476733</PMID>
<DateCompleted><Year>2021</Year>
<Month>03</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised><Year>2021</Year>
<Month>03</Month>
<Day>22</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-7913</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>57</Volume>
<Issue>3</Issue>
<PubDate><Year>2021</Year>
<Month>Mar</Month>
</PubDate>
</JournalIssue>
<Title>International journal of antimicrobial agents</Title>
<ISOAbbreviation>Int J Antimicrob Agents</ISOAbbreviation>
</Journal>
<ArticleTitle>Azithromycin, a questionable treatment for COVID-19.</ArticleTitle>
<Pagination><MedlinePgn>106280</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S0924-8579(21)00005-4</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijantimicag.2021.106280</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Belfaqeeh</LastName>
<ForeName>O</ForeName>
<Initials>O</Initials>
<AffiliationInfo><Affiliation>International Medicine Program, George Washington University School of Medicine and Health Sciences, Washington DC, USA. Electronic address: Obelfaqeeh@seha.ae.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Janapala</LastName>
<ForeName>R N</ForeName>
<Initials>RN</Initials>
<AffiliationInfo><Affiliation>International Medicine Program, George Washington University School of Medicine and Health Sciences, Washington DC, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Patel</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>International Medicine Program, George Washington University School of Medicine and Health Sciences, Washington DC, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Alhashmi</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>International Medicine Program, George Washington University School of Medicine and Health Sciences, Washington DC, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Pourmand</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>International Medicine Program, George Washington University School of Medicine and Health Sciences, Washington DC, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2021</Year>
<Month>01</Month>
<Day>19</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Netherlands</Country>
<MedlineTA>Int J Antimicrob Agents</MedlineTA>
<NlmUniqueID>9111860</NlmUniqueID>
<ISSNLinking>0924-8579</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004338">Drug Combinations</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C558899">lopinavir-ritonavir drug combination</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>2494G1JF75</RegistryNumber>
<NameOfSubstance UI="D061466">Lopinavir</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber>
<NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>83905-01-5</RegistryNumber>
<NameOfSubstance UI="D017963">Azithromycin</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>O3J8G9O825</RegistryNumber>
<NameOfSubstance UI="D019438">Ritonavir</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>X4W7ZR7023</RegistryNumber>
<NameOfSubstance UI="D008775">Methylprednisolone</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList><SupplMeshName Type="Protocol" UI="C000705127">COVID-19 drug treatment</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Int J Antimicrob Agents. 2021 Mar;57(3):106279</RefSource>
<PMID Version="1">33476734</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D017963" MajorTopicYN="N">Azithromycin</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004338" MajorTopicYN="N">Drug Combinations</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D061466" MajorTopicYN="N">Lopinavir</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008775" MajorTopicYN="N">Methylprednisolone</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019438" MajorTopicYN="N">Ritonavir</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>11</Month>
<Day>14</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>11</Month>
<Day>28</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2021</Year>
<Month>1</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2021</Year>
<Month>3</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2021</Year>
<Month>1</Month>
<Day>21</Day>
<Hour>20</Hour>
<Minute>11</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">33476733</ArticleId>
<ArticleId IdType="pii">S0924-8579(21)00005-4</ArticleId>
<ArticleId IdType="doi">10.1016/j.ijantimicag.2021.106280</ArticleId>
<ArticleId IdType="pmc">PMC7817454</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000458 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000458 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= CovidChloroV1 |flux= Main |étape= Corpus |type= RBID |clé= pubmed:33476733 |texte= Azithromycin, a questionable treatment for COVID-19. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:33476733" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a CovidChloroV1
![]() | This area was generated with Dilib version V0.6.38. | ![]() |